Forbes spotlights 30 healthcare innovators under 30

Amy Baxter | | Health Exec | Management

Forbes released its annual 30 under 30 list, spotlighting entrepreneurs, leaders and stars across 20 different industries, including healthcare.

Those on the healthcare list include capitalists investing in therapeutics, researchers looking for ways to improve diagnostic tests through CRISPR technology and entrepreneurs seeking to diagnose symptoms through telehealth.

Others are looking at stem cell therapies, cancer detection, easing the bottleneck of experimental drug testing and how to equip Africa with digital technology in healthcare.

The seventh Forbes 30 under 30 list featured 600 individuals. Nominations were vetted by a panel of judges and reporters.

See the full healthcare list below:

The 2019 30 Under 30

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

More than 1,000 hospitals earn $700M opioid crisis judgment
CEO of Amazon’s One Medical steps down
Nonprofit academic hospital receives criticism after running Super Bowl ad
Hospital delays opening after vandals sledgehammer holes into walls
Cigna announces changes to improve prior authorization, customer satisfaction
UnitedHealthcare in dispute with maternity practice over $1M in claims

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.